Efficacy and safety of mogamulizumab in Sézary syndrome with concomitant Crohn’s disease
Dear Editor, Mogamulizumab is a humanized, defucosylated monoclonal antibody targeting CC chemokine receptor 4 (CCR4), expressed on malignant T cells in cutaneous T-cell lymphomas (CTCL), particularly mycosis fungoides and Sézary syndrome. By enhancing antibody-dependent cellular cytotoxicity, mo...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
PAGEPress Publications
2026-05-01
|
| coleção: | Dermatology Reports |
| Assuntos: | |
| Acesso em linha: | https://journals.pagepress.net/dr/article/view/10823 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|